MR Imaging in Patients with Suspected Liver Metastases: Value of Liver-Specific Contrast Agent Gadoxetic Acid |
Lee, Kyung Hee
(Division of Abdominal Imaging, Department of Radiology, Seoul National University College of Medicine)
Lee, Jeong Min (Division of Abdominal Imaging, Department of Radiology, Seoul National University College of Medicine) Park, Ji Hoon (Division of Abdominal Imaging, Department of Radiology, Seoul National University Bundang Hospital) Kim, Jung Hoon (Division of Abdominal Imaging, Department of Radiology, Seoul National University College of Medicine) Park, Hee Sun (Department of Radiology, Konkuk University School of Medicine) Yu, Mi Hye (Division of Abdominal Imaging, Department of Radiology, Seoul National University College of Medicine) Yoon, Jeong-Hee (Division of Abdominal Imaging, Department of Radiology, Seoul National University College of Medicine) Han, Joon Koo (Division of Abdominal Imaging, Department of Radiology, Seoul National University College of Medicine) Choi, Byung Ihn (Division of Abdominal Imaging, Department of Radiology, Seoul National University College of Medicine) |
1 | Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, et al. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging. Invest Radiol 2010;45:96-103 DOI ScienceOn |
2 | Chakraborty DP. Analysis of location specific observer performance data: validated extensions of the jackknife freeresponse (JAFROC) method. Acad Radiol 2006;13:1187-1193 DOI ScienceOn |
3 | Vikgren J, Zachrisson S, Svalkvist A, Johnsson AA, Boijsen M, Flinck A, et al. Comparison of chest tomosynthesis and chest radiography for detection of pulmonary nodules: human observer study of clinical cases. Radiology 2008;249:1034-1041 DOI ScienceOn |
4 | Zheng B, Chakraborty DP, Rockette HE, Maitz GS, Gur D. A comparison of two data analyses from two observer performance studies using Jackknife ROC and JAFROC. Med Phys 2005;32:1031-1034 DOI ScienceOn |
5 | Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 2010;257:674-684 DOI ScienceOn |
6 | Kulemann V, Schima W, Tamandl D, Kaczirek K, Gruenberger T, Wrba F, et al. Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI? Eur J Radiol 2011;79:e1-e6 |
7 | Park HS, Lee JM, Choi HK, Hong SH, Han JK, Choi BI. Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT. J Magn Reson Imaging 2009;30:586-595 DOI ScienceOn |
8 | Park Y, Kim SH, Kim SH, Jeon YH, Lee J, Kim MJ, et al. Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: an initial experience. Korean J Radiol 2010;11:433-440 DOI ScienceOn |
9 | Ward J. New MR techniques for the detection of liver metastases. Cancer Imaging 2006;6:33-42 DOI |
10 | Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, et al. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol 2010;45:133-141 DOI ScienceOn |
11 | Doo KW, Lee CH, Choi JW, Lee J, Kim KA, Park CM. "Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor. AJR Am J Roentgenol 2009;193:W490-W496 DOI ScienceOn |
12 | Lowenthal D, Zeile M, Lim WY, Wybranski C, Fischbach F, Wieners G, et al. Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol 2011;21:832-840 DOI ScienceOn |
13 | Shimada K, Isoda H, Hirokawa Y, Arizono S, Shibata T, Togashi K. Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases. Eur Radiol 2010;20:2690-2698 DOI |
14 | Motosugi U, Ichikawa T, Onohara K, Sou H, Sano K, Muhi A, et al. Distinguishing hepatic metastasis from hemangioma using gadoxetic acid-enhanced magnetic resonance imaging. Invest Radiol 2011;46:359-365 DOI ScienceOn |
15 | Ahn SJ, Kim MJ, Hong HS, Kim KA, Song HT. Distinguishing hemangiomas from malignant solid hepatic lesions: a comparison of heavily T2-weighted images obtained before and after administration of gadoxetic acid. J Magn Reson Imaging 2011;34:310-317 DOI ScienceOn |
16 | Ba-Ssalamah A, Uffmann M, Saini S, Bastati N, Herold C, Schima W. Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol 2009;19:342-357 DOI |
17 | Danet IM, Semelka RC, Leonardou P, Braga L, Vaidean G, Woosley JT, et al. Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 2003;181:809-817 DOI ScienceOn |
18 | Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations. Radiology 2005;234:468-478 DOI ScienceOn |
19 | Clement O, Muhler A, Vexler VS, Kuwatsuru R, Berthezene Y, Rosenau W, et al. Comparison of Gd-EOB-DTPA and Gd-DTPA for contrast-enhanced MR imaging of liver tumors. J Magn Reson Imaging 1993;3:71-77 DOI ScienceOn |
20 | Halavaara J, Breuer J, Ayuso C, Balzer T, Bellin MF, Blomqvist L, et al. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT--a multicenter trial. J Comput Assist Tomogr 2006;30:345-354 DOI ScienceOn |
21 | Vogl TJ, Kummel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996;200:59-67 DOI |
22 | Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, et al. Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 2011;34:326-335 DOI ScienceOn |
23 | Hamm B, Staks T, Muhler A, Bollow M, Taupitz M, Frenzel T, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995;195:785-792 DOI |
24 | Reimer P, Rummeny EJ, Shamsi K, Balzer T, Daldrup HE, Tombach B, et al. Phase II clinical evaluation of Gd-EOBDTPA: dose, safety aspects, and pulse sequence. Radiology 1996;199:177-183 DOI |
25 | Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, et al. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 2009;192:1675-1681 DOI ScienceOn |
26 | Kim YK, Lee YH, Kwak HS, Kim CS, Han YM. Detection of liver metastases: Gadoxetic acid-enhanced three-dimensional MR imaging versus ferucarbotran-enhanced MR imaging. Eur J Radiol 2010;73:131-136 DOI ScienceOn |
27 | Lee MH, Kim SH, Kim H, Lee MW, Lee WJ. Differentiating focal eosinophilic infiltration from metastasis in the liver with gadoxetic acid-enhanced magnetic resonance imaging. Korean J Radiol 2011;12:439-449 DOI ScienceOn |
28 | Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO. MR imaging in patients with suspected liver metastases: value of liverspecific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 2007;6:43-52 DOI ScienceOn |
29 | Baker ME, Pelley R. Hepatic metastases: basic principles and implications for radiologists. Radiology 1995;197:329-337 DOI |
30 | Kim YK, Ko SW, Hwang SB, Kim CS, Yu HC. Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur Radiol 2006;16:1337-1345 DOI ScienceOn |
31 | Motosugi U, Ichikawa T, Nakajima H, Sou H, Sano M, Sano K, et al. Imaging of small hepatic metastases of colorectal carcinoma: how to use superparamagnetic iron oxideenhanced magnetic resonance imaging in the multidetectorrow computed tomography age? J Comput Assist Tomogr 2009;33:266-272 DOI ScienceOn |
32 | Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K, et al. Diagnosis of colorectal hepatic metastases: Contrastenhanced ultrasonography versus contrast-enhanced computed tomography versus superparamagnetic iron oxideenhanced magnetic resonance imaging with diffusionweighted imaging. J Magn Reson Imaging 2010;32:1132-1140 DOI ScienceOn |
33 | Stern W, Schick F, Kopp AF, Reimer P, Shamsi K, Claussen CD, et al. Dynamic MR imaging of liver metastases with Gd-EOBDTPA. Acta Radiol 2000;41:255-262 DOI |
34 | Onishi H, Murakami T, Kim T, Hori M, Iannaccone R, Kuwabara M, et al. Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology 2006;239:131-138 DOI ScienceOn |
35 | Schwartz L, Brody L, Brown K, Covey A, Tuorto S, Mazumdar M, et al. Prospective, blinded comparison of helical CT and CT arterial portography in the assessment of hepatic metastasis from colorectal carcinoma. World J Surg 2006;30:1892-1899; discussion 1900-1901 DOI |
36 | Holzapfel K, Eiber MJ, Fingerle AA, Bruegel M, Rummeny EJ, Gaa J. Detection, classification, and characterization of focal liver lesions: Value of diffusion-weighted MR imaging, gadoxetic acid-enhanced MR imaging and the combination of both methods. Abdom Imaging 2012;37:74-82 DOI ScienceOn |
37 | Motosugi U, Ichikawa T, Morisaka H, Sou H, Muhi A, Kimura K, et al. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology 2011;260:446-453 DOI ScienceOn |
38 | Choi JW, Lee JM, Kim SJ, Yoon JH, Baek JH, Han JK, et al. Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker. Radiology 2013;267:776-786 DOI ScienceOn |
39 | Sica GT, Ji H, Ros PR. CT and MR imaging of hepatic metastases. AJR Am J Roentgenol 2000;174:691-698 DOI ScienceOn |
40 | Lee JM, Zech CJ, Bolondi L, Jonas E, Kim MJ, Matsui O, et al. Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging. Korean J Radiol 2011;12:403-415 DOI ScienceOn |
41 | Chakraborty DP, Berbaum KS. Observer studies involving detection and localization: modeling, analysis, and validation. Med Phys 2004;31:2313-2330 DOI ScienceOn |